4-821-725
[1]. Anthony J Di Pasqua, et al. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer. J Nucl Med. 213 Jan;54(1):111-6.
[2]. Chris Oerlemans, et al. Holmium-lipiodol-alginate microspheres for fluoroscopy-guided embolotherapy and multimodality imaging. Int J Pharm. 215 Mar 3;482(1-2):47-53.
[3]. Monika Rai, et al. Infrared to visible upconversion in Ho3+/Yb3+ co-doped Y? O? phosphor: effect of laser input power and external temperature. Spectrochim Acta A Mol Biomol Spectrosc. 212 Nov:97:825-9.
[4]. Peixiong Zhang, et al. Deactivation effects of the lowest excited state of Ho3+ at 2.9 μm emission introduced by Pr3+ ions in LiLuF4 crystal. Opt Lett. 212 Dec 15;37(24):5241-3.
[5]. Quoc Lam Vuong, et al. Paramagnetic nanoparticles as potential MRI contrast agents: characterization, NMR relaxation, simulations and theory. MAGMA. 212 Dec;25(6):467-78.
P21-P24-P241-P28-P37+P378
GHS2
389
沪ICP备1719645号
